Skip to content

   Pharma Publications

Neuropsychopharmacology
  • UNRAVELing the synergistic effects of psilocybin and environment on brain-wide immediate early gene expression in mice
    Published on 2023-05-29
    3 years ago
  • How should we design future mechanistic and/or efficacy clinical trials?
    Published on 2023-05-26
    3 years ago
  • Region- and time- specific effects of ketamine on cerebral blood flow: a randomized controlled trial
    Published on 2023-05-25
    3 years ago
  • Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
    Published on 2023-05-25
    3 years ago
  • Dopamine D2 receptors in nucleus accumbens cholinergic interneurons increase impulsive choice
    Published on 2023-05-23
    3 years ago
  • Involvement of cortical input to the rostromedial tegmental nucleus in aversion to foot shock
    Published on 2023-05-23
    3 years ago
  • Accelerated TMS – moving quickly into the future of depression treatment
    Published on 2023-05-22
    3 years ago
« Previous 1 … 98 99 100 101 102 … 143 Next »
Journal of Psychopharmacology
  • Two newly-emerging substituted phenethylamines MAL and BOD induce differential psychopharmacological effects in rodents
    Published on 2020-07-10
    5 years ago
  • Blockade of D3 receptor prevents changes in DAT and D3R expression in the mesolimbic dopaminergic circuit produced by social stress- and cocaine prime-induced reinstatement of cocaine-CPP
    Published on 2020-07-10
    5 years ago
  • The recognition and management of protracted alcohol withdrawal may improve and modulate the pharmacological treatment of alcohol use disorder
    Published on 2020-07-10
    5 years ago
  • Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies
    Published on 2020-07-10
    5 years ago
  • Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca
    Published on 2020-07-10
    5 years ago
  • The innate immune system and neurogenesis as modulating mechanisms of electroconvulsive therapy in pre-clinical studies
    Published on 2020-07-10
    5 years ago
  • Brain entropy and neurotrophic molecular markers accompanying clinical improvement after ketamine: Preliminary evidence in adolescents with treatment-resistant depression
    Published on 2020-07-09
    5 years ago
« Previous 1 … 98 99 100 101 102 … 134 Next »
European Neuropsychopharmacology
  • Apolipoprotein E homozygous ε4 allele status: Effects on cortical structure and white matter integrity in a young to mid-age sample
    Published on 2021-02-27
    5 years ago
  • P.313 Deep brain stimulation for refractory obsessive-compulsive disorder: a cohort of 70 cases with predictors of response
    Published on 2021-02-26
    5 years ago
  • P.314 Effect of a focused social and communication intervention (SCI) on preterm children at risk for ASD: a pilot study.
    Published on 2021-02-26
    5 years ago
  • P.315 Undetermined predominant polarity in bipolar disorder: time to refine an overlooked population
    Published on 2021-02-26
    5 years ago
  • P.316 The use of cannabidiol in treating psychiatric disorder: a systematic review
    Published on 2021-02-26
    5 years ago
  • P.317 Psychosis in Parkinson’s disease
    Published on 2021-02-26
    5 years ago
  • P.318 Neurobiological marker and intervention for socio-communicative impairments in autism spectrum disorders
    Published on 2021-02-26
    5 years ago
« Previous 1 … 98 99 100 101 102 … 155 Next »

   Pharma Pub